Stockman Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q3 | $11.6M | Buy |
|
|||||
2025
Q2 | $10M | Buy |
|
|||||
2025
Q1 | $9.96M | Buy |
|
|||||
2024
Q4 | $7.35M | Buy |
|
|||||
2024
Q3 | $8.57M | Buy |
|
|||||
2024
Q2 | $7.49M | Buy |
|
|||||
2024
Q1 | $8.19M | Buy |
|
|||||
2023
Q4 | $7M | Buy |
|
|||||
2023
Q3 | $6.7M | Buy |
|
|||||
2023
Q2 | $6.41M | Buy |
|
|||||
2023
Q1 | $5.94M | Buy |
|
|||||
2022
Q4 | $5.51M | Buy |
|
|||||
2022
Q3 | $4.47M | Buy |
|
|||||
2022
Q2 | $6.49M | Buy |
|
|||||
2022
Q1 | $6.37M | Buy |
|
|||||
2021
Q4 | $6.23M | Buy |
|
|||||
2021
Q3 | $5.33M | Buy |
|
|||||
2021
Q2 | $5.31M | Buy |
|
|||||
2021
Q1 | $4.26M | Buy |
|
|||||
2020
Q4 | $3.85M | Buy |
|
|||||
2020
Q3 | $3.64M | Buy |
|
|||||
2020
Q2 | $3.81M | Buy |
|
|||||
2020
Q1 | $3.5M | Buy |
|
|||||
2019
Q4 | $4.23M | Sell |
|
|||||
2019
Q3 | $3.86M | Buy |
|
|||||
2019
Q2 | $3.44M | Buy |
|
|||||
2019
Q1 | $3.5M | Sell |
|
|||||
2018
Q4 | $3.22M | Buy |
|
|||||
2018
Q3 | $3.35M | Sell |
|
|||||
2018
Q2 | $3.41M | Sell |
|
|||||
2018
Q1 | $3.4M | Buy |
|
|||||
2017
Q4 | $2.79M | Buy |
|
|||||
2017
Q3 | $2.99M | Buy |
|
|||||
2017
Q2 | $604K | Sell |
|
|||||
2017
Q1 | $2.59M | Buy |
|
|||||
2016
Q4 | $2.3M | Buy |
|
|||||
2016
Q3 | $2.19M | Sell |
|
|||||
2016
Q2 | $2.29M | Sell |
|
|||||
2016
Q1 | $2.34M | Buy |
|
|||||
2015
Q4 | $1.94M | Buy |
|
|||||
2015
Q3 | $1.73M | Buy |
|
|||||
2015
Q2 | $1.83M | Buy |
|
|||||
2015
Q1 | $1.66M | Buy |
|
|||||
2014
Q4 | $1.32M | Buy |
|